@daltonventure
以生命科学为根，向硬科技生长
Recently, **Daotong Family company** — cable-driven AI robotics firm **Astribot** — unveiled its self-developed second-generation embodied foundation model, Lumo-2: the industry's first household latent world-action model, alongside Agent Philia, a physical AI symbiotic agent, advancing its "AI model — embodied OS — cable-driven
Recently, **Dalton Venture portfolio company Shanghai Rushen Robotics Technology Co., Ltd.** (hereinafter referred to as "Rushen Robotics") **announced the completion of a 100-million-yuan Pre-A funding round**, with investment from Qingsong Capital, leading listed computing power company Range Intelligent Computing Technology, and Pinghu Zexin. This round of financing will strongly support Rushen Robotics' continuous operation in real elderly care scenarios, data generation, and model iteration. This follows Dalton Venture's sole investment in Rushen Robotics in September 2025
On July 3, 2026, **Gestala**, a **Daotong Family portfolio company** and China's first company focused on ultrasound-based brain-computer interfaces, announced the completion of a **420 million RMB angel+ funding round**, while simultaneously holding an inauguration ceremony for its Shanghai headquarters — establishing a dual-headquarters strategic layout across "Chengdu + Shanghai".
Over the past year, TongDao's main focus areas have been three: brain-computer interfaces, bio-manufacturing, and new materials.
Dalton Venture launched Shanghai's first bio-manufacturing industry fund, injecting strong patient capital into the sector.
Existing shareholder Dalton Venture continued to increase its stake.
An **AIR incubated company and Tongtou Family portfolio company**, **Shuimu Molecular** has emerged as one of the most promising benchmark enterprises in AI-driven drug discovery, pursuing a dual-engine strategy of "tool empowerment + proprietary pipeline development." Its core achievements include the ChatDD intelligent agent framework, the OpenBioMed open-source platform, Shuimu Zhiliao — a new consumer-facing "super brain" tool for life sciences — and multimodal large models.
Leveraging a Hong Kong-based fund, DoTown deepens its cross-border innovation strategy bridging mainland China and the Greater Bay Area
Dedicated to becoming a leading benchmark in China's domestic wound closure space.
Minhang District Media Center has launched the "**Go, to the Lab**" series, going behind the scenes at Minhang's frontline research facilities to explore breakthrough technologies. This installment visits **a DaoTong portfolio company — KoSyne NeuroTech**.
